| Application no. and date | 16794472.7 (espacenet) (Federated) (European Patent Register), 20161024 | | Patent/reg. no. and date | DK/EP 3365366, 20210714 | | Publication date | 20180829 | | Priority no. and date | US 201562246113 P, 20151025, EP 16305211, 20160224, US 201662322029 P, 20160413, US 201662331169 P, 20160503 | | EP pub. no. and date |
EP 3365366 20180829 | | Effective date | | | Applicant/owner | THE USA, AS REPRESENTED BY THE SECRETARY,
DEPARTMENT OF HEALTH AND HUMAN SERVICES, National Institutes of Health
6011 Executive Boulevard, Suite 325
Rockville, MD 20852, US,
Sanofi, 46 Avenue de la Grande Armée
75017 Paris, FR | | Applicant ref. no. | 1610868 | | Inventor | LANGE, Christian, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
KRUIP, Jochen, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
BENINGA, Jochen, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
RAO, Ercole, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
QIU, Huawei, c/o Sanofi
55 Corporate Drive
Mail Code: 55a-505a
Bridgewater, NJ 08807, US,
YANG, Zhi-Yong, c/o Sanofi
55 Corporate Drive
Mail Code: 55A-505A
Bridgewater, NJ 08807, US,
NABEL, Gary, J., c/o Sanofi
55 Corporate Drive
Mail Code: 55A-505A
Bridgewater, NJ 08807, US,
XU, Ling, c/o Sanofi
55 Corporate Drive
Mail Code: 55A-505A
Bridgewater, NJ 08807, US,
WEI, Ronnie, c/o Sanofi
55 Corporate Drive
Mail Code: 55A-505A
Bridgewater, NJ 08807, US,
LEUSCHNER, Wulf, Dirk, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt Am Main, DE,
BEIL, Christian, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt Am Main, DE,
CONNORS, Mark, c/o National Institutes of Health
6011 Executive Boulevard
Suite 325
Rockville, MD 20852, US,
MASCOLA, John, R., c/o National Institutes of Health
6011 Executive Boulevard
Suite 325
Rockville, MD 20852, US,
KOUP, Richard, A., c/o National Institutes of Health
6011 Executive Boulevard
Suite 325
Rockville, MD 20852, US,
HUANG, Jinghe, c/o National Institutes of Health
6011 Executive Boulevard
Suite 325
Rockville, MD 20852, US,
DORIA-ROSE, Nicole, A., c/o National Institutes of Health
6011 Executive Boulevard
Suite 325
Rockville, MD 20852, US,
ZHOU, Tongqing, c/o National Institutes of Health
6011 Executive Boulevard
Suite 325
Rockville, MD 20852, US,
KWONG, Peter, D., c/o National Institutes of Health
6011 Executive Boulevard
Suite 325
Rockville, MD 20852, US,
KWON, Young, Do, c/o National Institutes of Health
6011 Executive Boulevard
Suite 325
Rockville, MD 20852, US,
PEGU, Amarendra, c/o National Institutes of Health
6011 Executive Boulevard
Suite 325
Rockville, MD 20852, US,
ASOKAN, Mangaiarkarasi, c/o National Institutes of Health
6011 Executive Boulevard, Suite 325
Rockville, MD 20852, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/42 (2006.01) , A61K 47/68 (2017.01) , A61P 31/18 (2006.01) , C07K 16/10 (2006.01) , C07K 16/46 (2006.01) | | Title | TRISPECIFIKKE OG/ELLER TRIVALENTE BINDINGSPROTEINER TIL FOREBYGGELSE ELLER BEHANDLING AF HIV-INFEKTION | | Int. application no. | US2016058540 | | Int. publication no. | WO2017074878 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
